Senate Panel Makes Surprisingly Fast Work Of ‘Surprise Medical Bills’ Package
The measure also includes a range of provisions designed to address health care costs.
1 In 6 Insured Hospital Patients Get A Surprise Bill For Out-Of-Network Care
On average, 16% of inpatient stays and 18% of emergency visits left a patient with at least one out-of-network charge, most of those came from doctors offering treatment at the hospital, according to a study by the Kaiser Family Foundation.
Sen. Alexander Details His Plan To Fix Surprise Medical Bills
A legislative package from Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.) would handle surprise medical bills by having insurers pay them the “median in-network rate,” meaning the rate would be similar to what the plan charges other doctors in the area for the same procedure.
Senators Agree Surprise Medical Bills Must Go. But How?
The Senate Health, Education, Labor and Pensions Committee is scheduled next week to mark up a massive legislative package on curbing health costs, but some of the details remain unresolved, including what formula to use to pay doctors and hospitals involved in surprise medical bills.
In Combating Surprise Bills, Lawmakers Miss Sky-High Air Ambulance Costs
The median cost of an air ambulance bill is more than $36,000 and seldom covered by insurance, sparking many consumer complaints. Yet none of the proposals introduced or circulating in Congress to fix surprise medical bills address these services.
Sen. Alexander Releases Bipartisan Plan To Lower Health Costs, End Surprise Bills
The Republican’s legislation, prepared with Sen. Patty Murray, the ranking Democrat on Alexander’s health committee, would be an ambitious lift because it also deals with prescription drug patents, health transparency and vaccine messaging.
Are Surprises Ahead For Legislation To Curb Surprise Medical Bills?
This high-profile issue has gained bipartisan attention, but it remains unclear if that’s enough to move it to the finish line. Here’s a review of the current state of play.
Is It A Feminist Right To Want More Sex? One Company Thinks A Pill Is The Answer
The savvy “Right to Desire” campaign relies on feminist messages and social media to raise patient awareness about low libido. Addyi, the only drug currently approved to treat it, has shown limited effectiveness.
Drug Industry Patents Go Under Senate Judiciary Committee’s Microscope
During a hearing Tuesday, panel members focused on how drug companies have used patents to allegedly protect their competitive edge and profits.
The Blame Game: Everyone And No One Is Raising Insulin Prices
During Wednesday’s House subcommittee hearing on insulin price hikes, drug makers and benefits managers pointed fingers at each other for the last decade’s 300% price increase, frustrating congressional representatives.